About 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide (PubChem CID 95158173) has the molecular formula C12H17N3O4
and a molecular weight of 267.28 g/mol. Its IUPAC name is 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide.
Analyze 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide?
The IUPAC name of 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide (CID 95158173) is 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide.
What is the SMILES notation for 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide?
The canonical SMILES for 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide is C[C@H](NC(=O)Cn1[nH]c(=O)ccc1=O)[C@H]1CCCO1.
What is the InChIKey of 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide?
The InChIKey is LVTVLPDIQDHZJS-DTWKUNHWSA-N. The full InChI is InChI=1S/C12H17N3O4/c1-8(9-3-2-6-19-9)13-11(17)7-15-12(18)5-4-10(16)14-15/h4-5,8-9H,2-3,6-7H2,1H3,(H,13,17)(H,14,16)/t8-,9+/m0/s1.
What are the key properties of 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide?
2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide has a molecular weight of 267.28 g/mol, XLogP of -0.78, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(3,6-dioxo-1H-pyridazin-2-yl)-N-[(1S)-1-[(2R)-oxolan-2-yl]ethyl]acetamide is sourced from PubChem (CID 95158173), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).